Undeterred, Pfizer continues its mega merger strategy

Posted on April 28, 2014 by Alexander Szewczak

Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.

This entry was posted in Pharmaceutical Industry and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.